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Injection of sestamibi during low-dose dobutamine (LDD)
infusion might improve tracer ability to detect viable
myocardium. This study investigated the potential value
of LDD technetium-99m sestamibi (sestamibi) single-pho-
ton emission computed tomography (SPECT) in predict-
ing functional recovery after revascularization by com-
paring its results with those of sestamibi SPECT at rest
and of LDD echocardiography. Before revascularization,
23 patients with chronic coronary artery disease and
regional left ventricular dysfunction underwent sesta-
mibi SPECT at rest and, on a separate day, LDD echo-
cardiography and sestamibi SPECT with tracer injection
during LDD infusion. Echocardiography at rest was re-
peated after revascularization. Semiquantitative sesta-
mibi uptake results (grading from 0 5 normal to 4 5
absent) and wall motion (grading from 1 5 normal to
4 5 dyskinesia) were evaluated with a 16-segment
model. The ventricular wall was divided into 3 vascular
territories. At follow-up, 20 of 32 asynergic vascular
territories showed functional recovery, whereas 12
showed no changes. For prediction of functional recov-
ery, LDD SPECT achieved better accuracy than SPECT at
rest (87% vs 65%, p <0.05); positive and negative
predictive values of LDD SPECT were 90% and 83%,
respectively, which was not significantly different from
the related LDD echocardiographic values (84% and
69%). Thus, LDD sestamibi SPECT appears to be a prom-
ising method for detecting myocardial viability, which
provides better accuracy than sestamibi SPECT at rest,
and achieves predictive values comparable to those of
LDD echocardiography. Q2000 by Excerpta Medica,
Inc.
(Am J Cardiol 2000;86:153–157)
The reliability of technetium-99m sestamibi (sesta-mibi) scintigraphy for the evaluation of myocar-
dial viability is controversial. Uptake correlates with
the extent of viable myocardium,1,2 but sestamibi scin-
tigraphy at rest seems to underestimate myocardial
viability compared with thallium-201 scintigraphy or
positron emission tomography,3,4 and shows just a fair
agreement with low-dose dobutamine (LDD) echocar-
diography.5–7 However, delayed imaging,8 quantita-
tive analysis of single-photon emission computed to-
mography (SPECT),9 or tracer injection under nitrate
administration10,11 improve sestamibi recognition of
viable myocardium. Because injection during LDD
infusion increases sestamibi uptake in recent infarc-
tion,12 this approach has been suggested to improve
viability detection.13 The aim of the present study was
(1) to investigate the ability of baseline and LDD
sestamibi SPECT to predict recovery of regional ven-
tricular function after revascularization in patients
with chronic coronary artery disease and left ventric-
ular dysfunction, and (2) to compare sestamibi SPECT
results with those of LDD echocardiography.
METHODS
Patient population: We prospectively enrolled 31
consecutive patients with coronary artery disease
scheduled for revascularization based on the indepen-
dent judgment of the referring physician. Sestamibi
SPECT and LDD echocardiographic results were not a
prerequisite for revascularization. Other inclusion cri-
teria were left ventricular dysfunction with .3 con-
tiguous asynergic segments, and $75% stenosis of the
related vessel. Of the potentially eligible patients, 3
were excluded because of a poor acoustic window.
We also excluded patients with recent myocardial
infarction or unstable angina, ventricular arrhythmias,
and conduction disturbances. After enrollment, we
excluded 8 patients because of revascularization re-
fusal or failure, ventricular aneurismectomy, or early
vessel reocclusion. Thus, the study group included 23
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patients (all men; mean age 59 6 12 years; mean left
ventricular ejection fraction 36 6 6%).
Study protocol: Before revascularization, patients
underwent baseline sestamibi SPECT at rest, LDD
echocardiography, and LDD sestamibi SPECT. Base-
line resting and LDD studies were performed in the
fasting state and in random order on 2 different days
with a 24-hour interval. Beta-adrenergic blocking
agents were withdrawn 48 hours before the test. Other
medications were not administered on the day of the
test. After baseline echocardiography, during contin-
uous electrocardiographic, blood pressure, and echo-
cardiographic monitoring, LDD infusion (5 mg/kg
body weight/min) was begun and continued for 5
minutes, and then increased to 10
mg/kg/min for another 5 minutes.
Sestamibi (740 Mbq) was injected at
minute 5 of the 10 mg/kg dose, which
was maintained for another 60 sec-
onds.14 After revascularization ($3
months for bypass grafting, 1 month
for coronary angioplasty), echocardi-
ography was repeated. All patients
gave written informed consent to
participate in the protocol.
Echocardiography: Echocardio-
grams were performed before, during
LDD, and at follow-up using all
views obtainable from the paraster-
nal and apical approach. Commercial
equipment (Hewlett Packard 1000, 2.5- and 3.5-MHz
transducers; Palo Alto, California) was used and im-
ages were recorded on videotape for off-line evalua-
tion. The left ventricular wall was divided into 16
segments and 3 vascular territories were considered.15
Segmental wall motion was scored as: 1 5 normal,
2 5 hypokinesia, 3 5 akinesia, and 4 5 dyskinesia.16
In evaluating wall motion abnormalities, attention was
also paid to systolic thickening in the central portion
of the segment. Echocardiographic baseline, LDD,
and follow-up studies were analyzed in random order
by 2 experienced observers who were blinded to the
data. Discrepancies were resolved by consensus. An
asynergic coronary territory was considered to have
contractile reserve in LDD echocardiography or func-
tional recovery in the follow-up control when, com-
pared with the baseline study, it showed a wall motion
improvement of $1 grade in $2 pertinent contiguous
asynergic segments.17,18
Sestamibi SPECT: Images were collected 1 hour af-
ter tracer injection using a single-head gamma camera
(Siemes Orbiter Digitrac 7500, Chicago, Illinois),
equipped with ultra-high resolution collimator, using a
15% window centered on the 140-keV photopeak of
technetium-99m. SPECT acquisition was performed
in step-and-shoot mode, 180° rotation arc, 32 projec-
tions of 40 seconds each, and 64 3 64 matrixes.
Images were reconstructed using filtered back-projec-
tion without attenuation or scatter correction. The
transaxial slices were realigned along the vertical and
horizontal long axes and the short axis of the heart.
The left ventricle was divided, considering the short-
axis slices at 2 different levels (basal and mid-ventric-
ular, 6 segments each) and the apical portion of the
FIGURE 1. Agreement between baseline SPECT at rest and LDD echocardiography in
territories with (left panel) and without (right panel) functional recovery.
FIGURE 2. Baseline resting (lower row) and LDD (upper row)
SPECT slices (from left to right: midventricular short axis, vertical
long axis, and horizontal long axis) of a patient with 3-vessel
coronary artery disease. A baseline severe inferior defect was
not modified in the LDD images; no improvement in regional
wall motion was registered after coronary artery bypass graft-
ing.
TABLE I Comparison of Sensitivity, Specificity, Predictive Values, and Accuracy of Low-Dose Dobutamine (LDD) Echocardiography,
Baseline Resting, and LDD Sestamibi SPECT for Predicting Functional Recovery
Sensitivity Specificity PPV NPV Accuracy
LDD echocardiography 16/20 (80%) 9/12 (75%) 16/19 (84%) 9/13 (69%) 25/32 (78%)
SPECT at rest 13/20 (65%) 8/12 (67%) 13/17 (76%) 8/15 (53%) 21/32 (65%)
LDD SPECT 18/20 (90%)* 10/12 (83%) 18/20 (90%) 10/12 (83%) 28/32 (87%)†
*p 5 0.06; †p ,0.05 versus SPECT at rest. Data are presented as number (%) of asynergic coronary artery territories.
NPV 5 negative predictive value; PPV 5 positive predictive value.
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mid-ventricular vertical and horizontal long-axis
slices (2 segments each), for a total of 16 segments.
The same segment model and the same segment attri-
bution to the pertinent coronary territory used for
echocardiography were applied to the SPECT imag-
es.15 Segment tracer uptake was graded by 2 experi-
enced observers who were blinded to the data, using a
5-point scoring scheme: 0 5 normal, 1 5 mildly
reduced, 2 5 moderately reduced, 3 5 severely re-
duced, and 4 5 absent uptake.19 Discrepancies were
resolved by consensus. Dysfunctional coronary terri-
tories probably included viable hibernating myocar-
dium in the presence of normal, mildly or moderately
reduced sestamibi uptake (score #2) in $2 pertinent
contiguous segments.20,21
Statistical analysis: Results are expressed as mean
value 6 SD. Positive and negative predictive values,
sensitivity, specificity, and accuracy were calculated
according to standard definitions. The comparison of
variables within groups was made with the Student’s t
test for paired data. The comparison of proportions
was made using the Fisher’s exact test. A p value of
,0.05 was considered significant.
RESULTS
Baseline and follow-up echocardiography: In the 23
patients, a total of 32 vascular territories supplied by
critically stenotic coronary vessels were successfully
revascularized. These territories
included 44 normal and 166 asyn-
ergic segments. After revascular-
ization, 73 abnormal segments
improved function. In terms of
coronary artery regions, 20 of 32
asynergic territories showed func-
tional recovery at follow-up,
whereas 12 showed no changes.
Prediction of functional recov-
ery: LDD ECHOCARDIOGRAPHY: No
complications occurred during in-
fusion and all patients completed
the LDD protocol. Heart rate in-
creased from 68 6 9 beats/min at
rest to 88 6 2 beats/min at peak
infusion (p ,0.005), and systolic
blood pressure increased from
128 6 17 mm Hg at rest to 144 6
28 mm Hg at peak infusion (p
,0.0002). The presence of con-
tractile reserve in LDD echocardi-
ography correctly identified 16 of
20 territories with functional re-
covery (sensitivity 80%); its ab-
sence was registered in 9 of 12
territories with unchanged dys-
function after revascularization
(specificity 75%). The related
positive predictive value was 84%
and the negative predictive value
was 69%, with an overall accu-
racy for prediction of functional
recovery of 78% (Table I).
BASELINE SESTAMIBI SPECT AT REST: SPECT at rest
showed normal or mild to moderate uptake in 13
regions with functional recovery and in 4 territories
with unchanged dysfunction (sensitivity 65%; speci-
ficity 67%), with 76% positive and 53% negative
predictive values for the presence of functional im-
provement after revascularization (Table I). Thus,
baseline resting sestamibi SPECT results were worse
than those obtained using LDD echocardiography.
Agreement between LDD echocardiography and
SPECT at rest was 63% (Figure 1).
FIGURE 3. Baseline resting and LDD SPECT of a patient with
1-vessel coronary artery disease. Same image disposition as in
Figure 2. The baseline anterior defect appears clearly reduced in
the LDD images. After coronary angioplasty of the left anterior
descending artery, significant functional recovery was observed.
FIGURE 4. Agreement between baseline SPECT at rest and LDD SPECT in territories with
(left panel) and without (right panel) functional recovery.
FIGURE 5. Agreement between LDD SPECT and LDD echocardiography in territories with
(left panel) and without (right panel) functional recovery.
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LDD SESTAMIBI SPECT: Figures 2 and 3 show 2 ex-
amples of resting and LDD perfusion images in our
patient population. After LDD infusion, 47 asynergic
segments with baseline score of $1 exhibited im-
provement in sestamibi uptake; of these segments, 29
had severely reduced or absent tracer uptake in base-
line sestamibi SPECT at rest. Therefore, the presence
of normal or mild to moderate sestamibi uptake in
LDD SPECT correctly identified 18 of 20 territories
with functional recovery (sensitivity 90%) and its
absence in 10 of 12 territories with unchanged dys-
function (specificity 83%). The related positive pre-
dictive value was 90% and the negative predictive
value 83%, with an overall accuracy for prediction of
functional recovery of 87%, which was significantly
higher (p ,0.05) than that achieved by SPECT at rest
(Table I). Agreement between resting and LDD
SPECT was 72% (Figure 4). No significant differ-
ences between LDD SPECT and LDD echocardiog-
raphy were found in sensitivity, specificity, predictive
values, and accuracy. Agreement between LDD echo-
cardiography and LDD SPECT was 78% (Figure 5).
Both LDD echocardiography and LDD SPECT were
positive in 16 regions; of these, 14 improved function
after revascularization (88%). Similarly, both tech-
niques were negative in 9 regions, and none of these
had improved function. Four territories showed via-
bility in LDD SPECT but no contractile reserve in
LDD echocardiography, and all of these improved at
follow-up. In contrast, 2 of 3 territories with severely
reduced sestamibi uptake in LDD SPECT but pre-
served contractile reserve in LDD echocardiography
improved function at follow-up (Figure 5).
DISCUSSION
LDD echocardiography and myocardial viability: Vi-
able myocardium may functionally improve in re-
sponse to inotropic stimulation, and contractile re-
serve elicited by LDD is a predictor of functional
recovery in patients with chronic coronary artery dis-
ease. In our study, positive and negative predictive
values of LDD echocardiography were 84% and 69%,
respectively, confirming the accuracy of this method
in predicting functional recovery after revasculariza-
tion reported by previous studies.22
Sestamibi SPECT and myocardial viability: Myocar-
dial uptake and retention of sestamibi is dependent on
cellular membrane integrity and mitochondrial func-
tion,23,24 and hence, reflect cellular viability. The
value of sestamibi imaging for the detection of viable
myocardium, however, remains controversial. In our
study, the predictive values for reversible dysfunction
derived from baseline sestamibi SPECT were lower
than that observed using LDD echocardiography,
which agrees with the results of previous studies com-
paring sestamibi with thallium-201 or positron emis-
sion tomography.3,4 Other studies, however, demon-
strate that delayed imaging,8 quantitative SPECT,9
and nitrate-enhanced imaging10,11 improve the value
of sestamibi scintigraphy for detecting myocardial vi-
ability.
LDD sestamibi SPECT and myocardial viability: Re-
cently, Barilla` et al12 demostrated that sestamibi in-
jection during LDD infusion increases uptake in areas
with recent infarction, and Roelants et al13 suggested
that this might improve the detection of viable myo-
cardium. Correlated with these observations, we ob-
served increased sestamibi uptake in LDD SPECT in
approximately 1/3 of segments with baseline defects,
and most of these segments were found in territories
with functional recovery. Our results demonstrate that
sestamibi injection during LDD improves tracer accu-
racy in the detection of myocardial viability. Com-
pared with baseline SPECT, LDD sestamibi imaging
achieves higher sensitivity and specificity with a sig-
nificant increase in accuracy for the prediction of
reversible dysfunction. Furthermore, LDD SPECT
predicts recovery of contractile function after revas-
cularization with accuracy comparable to that of LDD
echocardiography. Interestingly, in previous compar-
isons between thallium-201 scintigraphy and LDD
echocardiography, the sensitivity for the detection of
viable hibernating myocardium of perfusion imaging
appeared slightly higher than that of echocardiogra-
phy, but specificity was found to be significantly low-
er.25
Study limitations: The first limitation is the small
number of patients. This prevents comparison of the
different methods for the prediction of improvement
in global ventricular function, which is more impor-
tant from a clinical viewpoint than regional wall mo-
tion. Follow-up was performed early after revascular-
ization, whereas recent studies show that ventricular
function can still improve several months later.26 Si-
lent restenosis or graft occlusion could not be com-
pletely ruled out, because angiography was not per-
formed at follow-up. However, both problems should
not affect the direct comparison of the methods. Isch-
emia during LDD could reduce sestamibi uptake in
viable segments, and indeed in our series we observed
uptake decrease in LDD images in 1 territory with
functional recovery. This is a potential limitation of
LDD SPECT and also precludes the use of a high-dose
dobutamine protocol, which conversely improves the
reliability of echocardiography.27 Data were analyzed
on a coronary territory instead of a segment basis; this
has been done in other studies,10,16,17 and is reasonable
in terms of decision making because revascularization
usually involves an entire territory. Moreover, this
approach reduces the risk of misalignment between
echocardiography and SPECT. A final major limita-
tion is the lack of quantification of sestamibi uptake,
although visual scoring has been adopted for other
clinical studies designed to assess viability with per-
fusion imaging.5,20 It is not conceivable that quantita-
tive analysis would have affected baseline accuracy
differently from LDD SPECT accuracy. Reasonably,
the performance of SPECT compared with echocardi-
ography should be expected to improve using quanti-
tative imaging.
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